Sirion Therapeutics, a biopharmaceutical company, has entered into an agreement with Advanced Vision Research, a privately held ophthalmic specialty company, to co-promote, within the US, AVR's new MacuTrition oral retinal nutritional supplement and its recently launched NutriDox convenience kit for meibomian gland therapy.
Subscribe to our email newsletter
Under the agreement, the Sirion sales force will promote MacuTrition and the NutriDox convenience kit and provide sampling for the TheraTears line.
Barry Butler, president and CEO of Sirion, said: “The partnership with Advanced Vision Research continues and expands our mission to offer diversified products that will make a real difference to ophthalmologists and their patients.
“MacuTrition, the NutriDox convenience kit and the TheraTears product line dovetail strongly with our own products in development for dry age-related macular degeneration, dry eye and other ocular conditions.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.